logo
Plus   Neg
Share
Email

Elanco To Acquire Animal Health Division Of Bayer In $7.6 Bln Deal - Quick Facts

Elanco (ELAN), a global animal health company, has agreed to acquire the animal health division of Bayer AG (BAYN). The total deal is valued at $7.6 billion with a 70 percent to 30 percent cash-to-equity mix. Bayer AG will receive $5.32 billion in cash, and $2.28 billion or approximately 68 million Elanco Animal Health shares. The deal is anticipated to close in mid-2020.

Elanco expects the acquisition to provide adjusted EPS accretion in the first full year post-closing, and then high single to low double-digit percentage accretion in year two.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Pfizer said Friday it reached a multi-year deal with Gilead Sciences to manufacture and supply Gilead's investigational antiviral remdesivir for COVID-19 patients. Ferring Pharmaceuticals US is recalling various nasal sprays citing superpotency or amounts of desmopressin higher than specified, the U.S. Food and Drug Administration announced in a statement. The recall involves all lots on the market of DDAVP Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL, and STIMATE Nasal Spray 1.5 mg/mL. U.S. President Donald Trump has issued executive orders to ban Chinese mobile application TikTok as well as WeChat, citing a threat to national security and its economy. China's ByteDance Ltd. owns TikTok, a video-sharing mobile app, while Tencent Holdings Ltd. owns WeChat, a messaging, social media, and electronic payment app.
Follow RTT